CLOVOXAMINE AND DOXEPIN IN MAJOR DEPRESSIVE DISORDER - A DOUBLE-BLIND CONTROLLED TRIAL

被引：7
|
作者：
LODGE, GJ
FREEMAN, HL
机构：
[1] HOPE HOSP,SALFORD M6 8HD,LANCS,ENGLAND
[2] ROUNDWAY HOSP,DEVIZES SN10 5DS,WILTS,ENGLAND
来源：
BRITISH JOURNAL OF PSYCHIATRY | 1986年 / 148卷
关键词：
D O I：
10.1192/bjp.148.6.718
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：718 / 721
页数：4
相关论文
共 50 条
  • [41] A Randomized, Double-Blind, Placebo-Controlled Trial of Pramipexole Augmentation in Treatment-Resistant Major Depressive Disorder
    Cusin, Cristina
    Iovieno, Nadia
    Iosifescu, Dan V.
    Nierenberg, Andrew A.
    Fava, Maurizio
    Rush, A. John
    Perlis, Roy H.
    JOURNAL OF CLINICAL PSYCHIATRY, 2013, 74 (07) : E636 - E641
  • [42] Evidence for Efficacy and Tolerability of Vilazodone in the Treatment of Major Depressive Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial
    Rickels, Karl
    Athanasiou, Maria
    Robinson, Donald S.
    Gibertini, Michael
    Whalen, Heidi
    Reed, Carol R.
    JOURNAL OF CLINICAL PSYCHIATRY, 2009, 70 (03) : 326 - 333
  • [43] L-Carnosine combination therapy for major depressive disorder: A randomized, double-blind, placebo-controlled trial
    Araminia, Behin
    Shalbafan, Mohammadreza
    Mortezaei, Amirhosein
    Shirazi, Elham
    Ghaffari, Salomeh
    Sahebolzamani, Erfan
    Mortazavi, Seyyed Hosein
    Shariati, Behnam
    Ardebili, Mehrdad Eftekhar
    Aqamolaei, Ali
    Naderi, Sina
    Akhondzadeh, Shahin
    JOURNAL OF AFFECTIVE DISORDERS, 2020, 267 : 131 - 136
  • [44] EFFECT OF TRAMADOL AS AN ADJUNCTIVE PHARMACOLOGICAL TREATMENT FOR MAJOR DEPRESSIVE DISORDER: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
    Boin, Andre Campiolo
    Scarabelot, Luis Felipe
    Loureiro, Camila Marcelino
    Roza, Daiane Leite
    Graeff, Frederico Guilherme
    Del-Ben, Cristina Marta
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2025, 28 : i20 - i21
  • [45] A DOUBLE-BLIND PARALLEL STUDY TO COMPARE FLUOXETINE WITH DOXEPIN IN THE TREATMENT OF MAJOR DEPRESSIVE-DISORDERS
    TAMMINEN, TTA
    LEHTINEN, VV
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 1989, 4 : 51 - 56
  • [46] Duloxetine in the prevention of relapse of major depressive disorder - Double-blind placebo-controlled study
    Perahia, DG
    Gilaberte, I
    Wang, FJ
    Wiltse, CG
    Huckins, SA
    Clemens, JW
    Montgomery, SA
    Montejo, AL
    Detke, MJ
    BRITISH JOURNAL OF PSYCHIATRY, 2006, 188 : 346 - 353
  • [47] A randomized, double-blind, placebo-controlled study of citalopram in adolescents with major depressive disorder
    von Knorring, AL
    Olsson, GI
    Thomsen, PH
    Lemming, OM
    Hulten, A
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2006, 26 (03) : 311 - 315
  • [48] Double-blind, placebo-controlled study with reboxetine in inpatients with severe major depressive disorder
    Versiani, M
    Amin, M
    Chouinard, G
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2000, 20 (01) : 28 - 34
  • [49] Acid Folic Supplementation in Major Depressive Disorder Treatment: A Double-Blind Randomized Clinical Trial
    Sepehrmanesh, Zahra
    Omidi, Abdollah
    Gholampoor, Narges
    IRANIAN RED CRESCENT MEDICAL JOURNAL, 2017, 19 (02)
  • [50] Probiotics and magnesium orotate for the treatment of major depressive disorder: a randomised double blind controlled trial
    Strodl, Esben
    Bambling, Matthew
    Parnam, Sophie
    Ritchie, Gabrielle
    Cramb, Susanna
    Vitetta, Luis
    SCIENTIFIC REPORTS, 2024, 14 (01):
12345